Skip to main content Accessibility help
×
Hostname: page-component-7479d7b7d-8zxtt Total loading time: 0 Render date: 2024-07-12T10:09:10.766Z Has data issue: false hasContentIssue false

8 - Transplantation of Opioid-Producing Cells

Published online by Cambridge University Press:  06 July 2010

Christoph Stein
Affiliation:
Universitätsklinikum Benjamin Franklin, Berlin
Get access

Summary

Sources of Opioid-Producing Cells

Adrenal Medulla

Chromaffin cells of the adrenal medulla produce and secrete a variety of neuroactive substances in addition to the traditionally recognized catecholamines. Most notably, these cells are a rich source of neuropeptides and neurotrophic factors (see Carmichael and Stoddard, 1993, and Unsicker, 1993, for reviews). Although several of these latter agents may be useful in pain control, the adrenal medulla has been well characterized as a rich source of opioid peptides (Viveros et al., 1979; Hexum et al., 1980; Lewis et al., 1980; Yang et al., 1980; Kilpatrick et al., 1982). These are primarily derived from the proenkephalin A precursor; thus, the active peptides are predominantly those of the enkephalin-containing family. In bovine adrenal gland, proenkephalin mRNA levels are 20–400 times higher than in the brain (Pittius et al., 1985). Levels of opioid peptide production in the adrenal medulla is species dependent to some extent, with high levels found in bovine, porcine, and canine glands and lower levels in rodents (Hexum et al., 1980; Yang et al., 1980). However, both proenkephalin mRNA and opioid peptide levels increase in the rat adrenal with denervation and with time in tissue culture, suggesting that environmental factors have a strong influence on opioid peptide production (Kilpatrick et al., 1984; Zhu et al., 1992).

In contrast to the CNS, where proenkephalin is processed nearly completely to the pentapeptides, Met5-enkephalin and Leu5-enkephalin, the adrenal medulla in addition processes this precursor to several small, intermediate, and larger peptides that may contain single or multiple encrypted pentapeptide sequences (Lewis et al., 1980; Stern et al., 1980; Liston et al., 1984; Wilson, 1991).

Type
Chapter
Information
Opioids in Pain Control
Basic and Clinical Aspects
, pp. 143 - 165
Publisher: Cambridge University Press
Print publication year: 1998

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×